Mount Sinai Hospital

Dr. Ken Croitoru

The Best Medicine

A key reason behind Dr. Ken Croitoru's decision to join Mount Sinai Hospital's Zane Cohen Centre for Digestive Diseases was its excellence in clinical research. His confidence was well placed. In 2008, the clinician-scientist was named lead investigator of The Gem Project, an unprecedented Mount Sinai Hospital-led study of healthy people genetically at risk of developing Crohn's disease. The five-year initiative links every major Inflammatory Bowel Disease (IBD) centre in the country, and has recruitment sites in the United States and Israel. It was launched with over $5 million in funding from the Crohn's and Colitis Foundation of Canada, and in 2010 received $2.5 million from the Canadian Institutes of Health Research. Formerly with McMaster University, where he had established a distinguished research program, Dr. Croitoru now leads a global project which could answer the most puzzling question behind IBD: what triggers this difficult and painful condition?

"This study has never been done before," says Dr. Croitoru. "Mount Sinai's ability to execute The GEM Project positions us to rapidly translate new findings and new prevention and treatment strategies —transforming patient outcomes."